Hepta
hepta.bio
Actively hiring
Health Care
Precision Medicine
Molecular Diagnostics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$6.7M
1 round on record
Latest round
$6.7M
Seed · Nov 2025 · 10 mo ago
Backers
1
Illumina Ventures
The money's age
Fresh money
10 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Nov 2025 | $6.7M | Felicis lead, Illumina Ventures lead | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting…
Tagomics is advancing precision medicine through innovative liquid biopsy solutions for drug safety and cancer detection.
Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw.
Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™…
Altum Sequencing delivers ultra-sensitive ctDNA detection for cancer monitoring and MRD assessment. Precision liquid biopsy solutions for…
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…
News
Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Enabling Precision Medicine in Obesity and MASH
FOSTER CITY, Calif., May 05, 2026--GLP-1 medicines are being prescribed for weight loss at a scale the healthcare system has never managed before. Clinicians can measure weight loss. What they still cannot see, in any scalable, non-invasive way, is which
Read more
Report
May 5, 2026 Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Enabling Precision Medicine in Obesity and MASH
Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Enabling Precision Medicine in Obesity and MASH
Read more
Report
Hepta Pushes Frontiers of Cell-Free DNA-Based Dx With Assay for Liver Disease
The liquid biopsy startup is the realization of a dream held by two young engineering students 20 years ago and half a world away.
Read more
Report
Grail Veterans Launch AI Liquid Biopsy Company
Explore Diagnostics World's news highlights to stay updated on the regulatory and commercialization landscape of diagnostics. Explore articles now!
Read more
Report
Nov 10, 2025 Hepta unveils first multi-omic atlas of MASH, linking liver pathway biology to cfDNA methylation in blood.
Hepta unveils first multi-omic atlas of MASH, linking liver pathway biology to cfDNA methylation in blood.
Read more
Report
Hepta: $6.7 Million Seed Funding Closed To Advance Liquid Biopsy-Based AI Diagnostics For Chronic Liver Disease
Hepta, a biotechnology company developing a transformer-based artificial intelligence platform to analyze the cell-free DNA epigenome, has emerged from stealth with $6.7 million in seed funding. The round was led by Felicis Ventures and Illumina Ventures,
Read more
Report
Nov 5, 2025 Illumina and GRAIL veterans launch Hepta with first liquid-biopsy-native AI that detects liver disease with tissue-level biological insights.
Illumina and GRAIL veterans launch Hepta with first liquid-biopsy-native AI that detects liver disease with tissue-level biological insights.
Read more
Report
HEPTA Medical: Thermal Ablation Therapy Device Company Raises €5.7 Million (Series A)
HEPTA Medical-a private medical device company focused on providing efficient, safe, and minimally invasive thermal ablation therapy for early-stage lung cancer-announced today that it has raised €5.7 million in the first close of its Series A funding rou
Read more
Report
Show more news
Financials
Total raised
$6.7M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2025 | $6.7M | Details |